Home / Stocks / AEHR

Aehr Test Systems (AEHR, Chipmaking equipment) Stock Valuation & Fair Value

Significantly overvalued

Aehr Test Systems (AEHR, Chipmaking equipment) trades at a current P/E of 158.4, about 363% above its historical normal valuation, with a forward growth estimate above 100% and a PEG of 1.04. Priced at its historical normal P/E of 34.2 on the same blended earnings, the 2026-11-06 close of $53.57 corresponds to about $11.60 a share. This is a valuation reference, not a price target.

How to read these numbers: the PEG ratio and current P/E versus normal P/E.

Current P/E
158.4
Normal P/E
34.2
PEG
1.04
Fwd growth
>100%
Div yield
0.0%
RSI (14)
39.3
Neutral
Technical context
  • Price $53.57 at the Nov 6 close, 13.5% below the 20-day average ($61.92) and 32.8% below the 50-day ($79.76).
  • RSI (14) at 39.3.
  • 52-week range $19.40 to $145.61: the price is 63.2% below the high and 176.1% above the low.

The Street vs SeerForecast

Wall Street's mean price target for AEHR is $128.00 across 5 analysts, 138.9% above the current price. The average analyst rating is Strong Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been significantly overvalued since 2026-10-19.

Current P/E and rating by weekCurrent P/E moved from 195.6 to 162.3 between 2026-10-16 and 2026-10-30, against a normal P/E of 34.2, with 0 rating changes over 3 recorded weeks.2026-10-16: P/E 195.6, Significantly overvalued, recorded live 2026-10-192026-10-23: P/E 170.7, Significantly overvalued, recorded live 2026-10-262026-10-30: P/E 170.7, Significantly overvalued, recalculated for the week of 2026-10-312026-10-30: P/E 162.3, Significantly overvalued, recorded live 2026-11-0250.0100.0150.0Oct 16Oct 20Oct 23Oct 26Oct 30Normal P/E 34.2
Significantly overvalued

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

WeekCurrent P/EPremium to normal P/ERating
2026-10-19P/E 195.6+472%Significantly overvalued
2026-10-26P/E 170.7+399%Significantly overvalued
2026-10-31P/E 170.7+399%Significantly overvalued (recalculated)
2026-11-02P/E 162.3+375%Significantly overvalued ← now

Frequently asked questions

Is Aehr Test Systems stock overvalued?

At a current P/E of 158.4 versus its historical normal P/E of 34.2, Aehr Test Systems trades about 363% above its typical valuation, with a PEG of 1.04 on forward growth above 100%. tickerseer currently rates it significantly overvalued.

What is Aehr Test Systems's fair value and PEG?

Aehr Test Systems trades at a current P/E of 158.4 against a historical normal P/E of 34.2, a PEG of 1.04, and a forward growth estimate above 100%. Priced at its historical normal P/E of 34.2 on the same blended earnings, the 2026-11-06 close of $53.57 corresponds to about $11.60 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Aehr Test Systems changed?

tickerseer's rating has been significantly overvalued since 2026-10-19.

What is the analyst price target for Aehr Test Systems?

The mean Wall Street price target for Aehr Test Systems is $128.00 across 5 analysts, 138.9% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Chipmaking equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.